# US 2006/0154279 A1 · Extracellular serine protease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0154279 A1
- Document ID: US20060154279A1
- Status: Published application
- Kind: A1
- Application number: 11/295,040
- Filed: 2005-12-05
- Published: 2006-07-13
- Earliest claimed: 1997-08-21
- Assignees: Board of Trustees of the University of Arkansas
- Inventors: Lowell Underwood; Timothy O'Brien
- Web page: https://patentgrep.com/patent/US20060154279A1

## CPC

- C12N 9/6424: {Serine endopeptidases (3.4.21)}
- Y10T 436/25: including sample preparation
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The present invention provides a DNA encoding a TADG-14 protein selected from the group consisting of: (a) isolated DNA which encodes a TADG-14 protein; (b) isolated DNA which hybridizes to isolated DNA of (a) above and which encodes a TADG-14 protein; and (c) isolated DNA differing from the isolated DNAs of (a) and (b) above in codon sequence due to the degeneracy of the genetic code, and which encodes a TADG-14 protein. Also provided is a vector capable of expressing the DNA of the present invention adapted for expression in a recombinant cell and regulatory elements necessary for expression of the DNA in the cell.

## Claims

### Claim 1

A method of diagnosing cancer in an individual, comprising:
detecting Tumor Antigen Derived Gene-14 (TADG-14) protein or TADG-14 mRNA in a biological sample of an individual, wherein the presence of TADG-14 protein or TADG-14 mRNA indicates the individual has a cancer.

### Claim 2 (depends on 1)

The method of claim 1, wherein detecting TADG-14 comprises:
contacting said biological sample with a labeled-antibody specific for TADG-14 protein; and
determining if said labeled-antibody binds to a component of the biological sample via the detection of the label.

### Claim 3 (depends on 2)

The method of claim 2, wherein said TADG-14 protein has the amino acid sequence shown in SEQ ID NO: 7.

### Claim 4 (depends on 1)

The method of claim 1, wherein detecting TADG-14 comprises:
contacting mRNA present within cells comprising the biological sample with a labeled hybridization probe having a sequence complementary to a DNA encoding TADG-14 protein or a fragment of said DNA; and
determining if said labeled hybridization probe hybridizes with mRNA via detection of the label.

### Claim 5 (depends on 4)

The method of claim 4, wherein said DNA encoding TADG-14 protein has the sequence shown in SEQ ID No. 6.

### Claim 6 (depends on 5)

The method of claim 5, wherein said DNA encodes a TADG-14 protein with the amino acid sequence shown in SEQ ID NO: 7.

### Claim 7 (depends on 1)

The method of claim 1, wherein said biological sample is blood, cells, tissue, or plasma.

### Claim 8 (depends on 1)

The method of claim 1, wherein said cancer is ovarian cancer, breast cancer, colon cancer, or prostate cancer.

### Claim 9 (depends on 1)

The method of claim 1, wherein said TADG-14 protein is detected in vivo.

### Claim 10

A method of diagnosing cancer in an individual, comprising:
contacting a biological sample of an individual with a labeled-antibody specific for TADG-14 protein; and
determining if said labeled-antibody binds to a component of the biological sample via the detection of the label, wherein the presence of bound labeled antibody is indicative of the presence of a cancer in the individual.

### Claim 11 (depends on 10)

The method of claim 10, wherein said TADG-14 protein has the amino acid sequence shown in SEQ ID NO: 7.

### Claim 12 (depends on 10)

The method of claim 10, wherein said biological sample is blood, cells, tissue, or plasma.

### Claim 13 (depends on 10)

The method of claim 10, wherein said antibody detects TADG-14 protein in vivo.

### Claim 14 (depends on 10)

The method of claim 10, wherein said cancer is ovarian cancer, breast cancer, colon cancer, or prostate cancer.

### Claim 15

A method of diagnosing cancer in an individual, comprising:
obtaining a cell sample from an individual;
contacting mRNA obtained from the cell sample with a labeled hybridization probe having a sequence complementary to a DNA encoding TADG-14 protein or a fragment of said DNA; and
determining if said labeled hybridization probe hybridizes with the mRNA via detection of the label, wherein the hybridization of the labeled probe to the mRNA is indicative of the presence of a cancer in the individual.

### Claim 16 (depends on 15)

The method of claim 15, wherein said DNA encoding TADG-14 protein has the sequence shown in SEQ ID No. 6.

### Claim 17 (depends on 16)

The method of claim 16, wherein said DNA encodes a TADG-14 protein with the amino acid sequence shown in SEQ ID NO: 7.

### Claim 18 (depends on 15)

The method of claim 15, wherein said cancer is ovarian cancer, breast cancer, colon cancer, or prostate cancer.
